Overexpression of TLR7 contributes to the development of preeclampsia through suppression of the PI3K-Akt signaling pathway
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Over-activation of Toll-like receptor 7 (TLR7) contributes to preeclampsia by impairing trophoblast function. Targeting TLR7 offers a potential therapeutic strategy for preeclampsia.
Area Of Science
- Reproductive biology
- Immunology
- Molecular genetics
Background
- Preeclampsia is a pregnancy complication with significant maternal and fetal risks.
- The precise molecular mechanisms driving preeclampsia remain incompletely understood.
- Identifying key genetic and signaling pathways involved is crucial for developing effective interventions.
Purpose Of The Study
- To identify key genes and pathways involved in preeclampsia pathogenesis.
- To elucidate the role of Toll-like receptor 7 (TLR7) in preeclampsia development.
- To explore potential therapeutic targets for preeclampsia.
Main Methods
- Transcriptome analysis of placental tissues from preeclampsia patients and controls.
- In vivo induction of preeclampsia-like symptoms in mice using a TLR7 agonist.
- In vitro studies involving TLR7 overexpression in HTR8/Svneo cells.
- Co-analysis of transcriptomic data to identify regulatory pathways.
Main Results
- Toll-like receptor (TLR) signaling pathway identified as a central network, with TLR7 significantly altered in preeclampsia.
- TLR7 agonist administration induced preeclampsia-like symptoms in mice, including hypertension and altered angiogenic factors (sFlt, sEng).
- TLR7 overexpression in HTR8/Svneo cells reduced cell proliferation and migration, linked to PI3K-Akt and P53 signaling pathways, impacting trophoblast function and placental implantation.
Conclusions
- Over-activation of TLR7 is implicated in preeclampsia development.
- TLR7 signaling pathways, including PI3K-Akt, play a critical role in suppressing trophoblast migration and invasion.
- TLR7 represents a potential therapeutic target for preeclampsia treatment.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...